Yu Wang
8Patents
2h-index
9Co-inventors
44Inventor score
Filing activity: Apr 1, 2002 → Jun 5, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6884575B2 | Phosphoprotein target for insulin and its antagonists | Physics | 13 | Expired |
| US7365170B2 | Adiponectin and uses thereof | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7645616B2 | Use of lipocalin-2 as a diagnostic marker and therapeutic target | Emerging Cross-Sectional Technologies | 1 | Active |
| US12215170B2 | Anti-TMPRSS6 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8044182B2 | Adiponectin and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US8481032B2 | Lipocalin-2 antibodies for methods of treatment | Emerging Cross-Sectional Technologies | 0 | Active |
| US8030097B2 | Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks | Emerging Cross-Sectional Technologies | 0 | Active |
| US11866513B2 | Anti-TMPRSS6 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.